MGFA has partnered with Bionews to feature the “Myasthenia Gravis News” feed on our MGFA website. We are excited to offer the MG Community this insightful and informative news feed that covers many aspects of living with myasthenia – from research and study results to managing MG, helpful tips, and important news from across the MG World.
Myasthenia Gravis News is a digital platform intended to provide the myasthenia gravis (MG) community with the most recent news and information on MG, as well as first-hand community perspectives from patient and caregiver columnists. All articles on Myasthenia Gravis News are original content produced by in-house writers and editors. Occasionally, BioNews seeks the opinion of outside experts for interviews and Q&As.
Myasthenia Gravis News – The Web’s Daily Resource for Myasthenia Gravis News
- My twin loves junk food, but a veggie and fruit diet is helping him combat MG
by Allen Francis on January 16, 2026 at 3:00 pmAs I chatted recently with my twin brother, Aaron, on a video call, I noticed he was sipping a smoothie. This was very odd to me. Aaron is a serious fitness nut, and before he developed myasthenia gravis (MG), he was always exercising. But he was never a healthy eater; we are both fast-food aficionados. The post My twin loves junk food, but a veggie and fruit diet is helping him combat MG appeared first on Myasthenia Gravis News.
- My secret book of survival in life with myasthenia gravis
by Sarah Bendiff on January 15, 2026 at 3:00 pmSome days I feel like a vampire, constantly seeking fresh energy to nourish myself and keep going. From my small experience with other people living with illness, I have learned that each of us has a secret book of survival. The following is mine, to help me confront life with myasthenia gravis (MG). Comfort from The post My secret book of survival in life with myasthenia gravis appeared first on Myasthenia Gravis News.
- MG symptoms in US strike earlier and harder depending on race and ethnicity
by Marisa Wexler, MS on January 15, 2026 at 1:00 pmNew research reveals that race and ethnicity significantly influence how myasthenia gravis (MG) manifests in U.S. patients, with African American and Hispanic individuals developing the autoimmune condition at much younger ages and experiencing more severe initial symptoms. The study, drawing from two large national databases, highlights a stark divide in disease onset. While white patients The post MG symptoms in US strike earlier and harder depending on race and ethnicity appeared first on Myasthenia Gravis News.
- FDA grants priority review for expanded Vyvgart use in gMG
by Margarida Maia, PhD on January 14, 2026 at 1:00 pmThe U.S. Food and Drug Administration (FDA) granted priority review to Argenx’s application seeking to expand the approval of Vyvgart (efgartigimod alfa-fcab) to adults with generalized myasthenia gravis (gMG) who test negative for anti-acetylcholine receptor (AChR) antibodies. If the supplemental biologics license application is approved, the infusion treatment would become available to a broader population The post FDA grants priority review for expanded Vyvgart use in gMG appeared first on Myasthenia Gravis News.
- Swallowing issues highly common in MG patients: Study review
by Andrea Lobo on January 13, 2026 at 1:00 pmDysphagia, or difficulty swallowing, is highly prevalent in people with myasthenia gravis (MG) and may be associated with severe complications, including lung infections caused by food aspiration into the airways. That is according to a review of studies assessing dysphagia in MG patients using objective instrumental tests and subjective scores of disease severity and swallowing The post Swallowing issues highly common in MG patients: Study review appeared first on Myasthenia Gravis News.
** MGFA Disclaimer – Please read
Myasthenia Gravis Foundation of America (MGFA) and Bionews, Inc. (specifically Myasthenia Gravis News) have entered into a limited agreement that allows for the MGFA to post a link to Myasthenia Gravis News on the myasthenia.org website. Myasthenia Gravis News is a digital platform intended to provide the myasthenia gravis (MG) community with the most recent news and information on MG, as well as first-hand community perspectives from patient and caregiver columnists. All articles on Myasthenia Gravis News are original content produced by in-house writers and editors. Occasionally, Bionews seeks the opinion of outside experts for interviews and Q&As.
The publishing team at Myasthenia Gravis News is made up of science writers and editors, most of whom have PhDs in the life sciences; veteran journalists; and columnists who are members of the MG community. Together, they attempt to ensure that all content published on Myasthenia Gravis News is relevant, accurate, informative, relatable, and easy to understand.
Each piece of content is carefully selected and written by Bionews writers with the MG community in mind. Sources for news stories and resource pages include peer-reviewed studies, press releases, announcements, interviews, webinars, and conference sessions, among others. All articles go through a stringent fact-checking and editing procedure as part of Bionews’ process to ensure they are accurate, objective, comprehensive, and well-explained.
Columns are written by MG patients and caregivers who provide an intimate look at what it’s like to live with the disease. While columns are largely opinion and perspective pieces, each one still goes through a comprehensive editing and fact-checking process by Bionews editors to ensure clarity, accuracy, and fairness.
Myasthenia Gravis News’ site is strictly a news and information website about the disease. It DOES NOT provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of a licensed physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. The information provided is for educational purposes only and does not substitute for professional medical advice.
The content reflects the unique experiences of the authors and is not necessarily the opinion, views, or recommendations of the MGFA. Medical advisors and clinicians associated with or partnering with the MGFA do not peer review articles and information posted on the Myasthenia Gravis News platform or website. MGFA should not be liable for any information, opinions, articles, advice, guidance, or details posted on the Myasthenia Gravis News site. MGFA has posted this platform as a service to the MG community. Please consult with your doctor and healthcare professionals for specific recommendations and advice pertaining to your healthcare/treatment.